Parkwood LLC’s Novartis AG Position
Does Parkwood LLC own Novartis AG (NVS)? Yes — 163.4K shares worth $25M (+2.21% of its 13F portfolio) as of Q1 2026, up from 147.3K shares the prior filed quarter.
Position Value
$25M
Q1 2026
Shares
163.4K
% of Portfolio
+2.21%
Quarters Held
13
currently held
Position History NVS
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 163.4K | $25M | +2.21% |
| Q4 2025 | 147.3K | $20M | +1.57% |
| Q3 2025 | 133.0K | $17M | +1.55% |
| Q2 2025 | 227.3K | $28M | +2.47% |
| Q1 2025 | 106.4K | $12M | +1.09% |
| Q4 2024 | 118.0K | $11M | +1.30% |
| Q3 2020 | 59.1K | $5M | +0.79% |
| Q2 2020 | 57.6K | $5M | +0.90% |
| Q1 2020 | 122.1K | $10M | +2.05% |
| Q4 2019 | 72.3K | $7M | +1.44% |
| Q3 2019 | 69.5K | $6M | +1.22% |
| Q2 2019 | 134.4K | $12M | +2.62% |
| Q1 2019 | 67.6K | $7M | +1.27% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Parkwood LLC’s full portfolio or all institutional holders of NVS.